Published Date: 24 Apr 2023
The revised schedule for the admissions entrance exam and application status has been made public by the All India Institute of Medical Sciences (AIIMS Delhi).
Read Full NewsFindings from a phase 2 trial highlighted lacosamide's effectiveness and safety in treating neonatal seizures, showing significant seizure reduction and tolerability in patients.
Here's some of what is coming soon to NeurologyLive® this week.
Ovid Therapeutics' OV329 shows promise as a safe, effective GABA-AT inhibitor for treating drug-resistant seizures, with strong phase 1 trial results.
FDA-approved RBL shows 95% success and sustained microbiome restoration in recurrent C. difficile.
5 Pulmonology Headlines You Missed in November 2025
Adjunctive Lumateperone Significantly Improves MDD Symptoms by Day 43
Stage 5 CKD May Reverse Female Survival Advantage
1.
New analysis helps discern benign from malignant thyroid growths
2.
Living in a more pedestrian-friendly area may reduce the risk of cancer and obesity-related diseases.
3.
Medical Journal March 29, 2023
4.
Psychiatric Disorders Are Common in Dementia Patients.
5.
Because of the Medicare mail-order drug rule, oncologists run the risk of self-referral violations.
1.
A New Hope: How Procarbazine is Revolutionizing Cancer Treatment
2.
The Future is Now: Navigating the Precision Revolution in Oncology Treatment
3.
ctDNA in Oncology: Transforming MRD Assessment, Disease Tracking, and Early Cancer Detection
4.
Precision Medicine and Genomics: Harnessing Longitudinal Data Modeling to Decode Cancer Progression
5.
Exploring New Treatment Options for Hemophilia: A Journey into the Unknown
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Efficient Management of First line ALK-rearranged NSCLC - Part IV
2.
Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
5.
Updates on the First Line Management of ALK+ NSCLC
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation